Abstract
Lipase inhibitors have generated a great interest because they could help in the prevention or the therapy of lipase‐related diseases. Therefore, the aim of this work was to evaluate the inhibitory effect of secondary metabolites extracts such as phenolic compounds and saponins of three Algerian medicinal plants: Achillea santolina, Inonotus hispidus and Zizyphus lotus, indeed their antiradicalaire activity using DPPH• (1, 1‐diphenyl‐2‐picryl‐hydrazyl). The phenolic extracts have shown a strong antiradicalaire activity than the saponin extracts with EC50 values ranged from 6 to 11 μg/ml and from 51 to 82 μg/ml, respectively. The enzymatic inhibition produced by these plant extracts is described here for the first time. The results have shown that the phenolic extracts are more potent than the saponin extracts with Ki values ranged from 0.011 mg/ml to 0.027 mg/ml for phenolic extracts, and ranged from 0.071 mg/ml to 0.69 mg/ml for saponin extracts. The nature, mechanism and possible physiological relevance of lipase inhibition by extract components are discussed.
Keywords: Achillea santolina, Inonotus hispidus, Zizyphus lotus, Candida rugosa lipase, inhibition, saponins extracts, phenolic extracts, DPPH•.
Current Enzyme Inhibition
Title:Inhibition of Candida rugosa Lipase by Secondary Metabolites Extracts of Three Algerian Plants and their Antioxydant Activities
Volume: 9 Issue: 1
Author(s): K. Benarous, A. Djeridane, A. Kameli and M. Yousfi
Affiliation:
Keywords: Achillea santolina, Inonotus hispidus, Zizyphus lotus, Candida rugosa lipase, inhibition, saponins extracts, phenolic extracts, DPPH•.
Abstract: Lipase inhibitors have generated a great interest because they could help in the prevention or the therapy of lipase‐related diseases. Therefore, the aim of this work was to evaluate the inhibitory effect of secondary metabolites extracts such as phenolic compounds and saponins of three Algerian medicinal plants: Achillea santolina, Inonotus hispidus and Zizyphus lotus, indeed their antiradicalaire activity using DPPH• (1, 1‐diphenyl‐2‐picryl‐hydrazyl). The phenolic extracts have shown a strong antiradicalaire activity than the saponin extracts with EC50 values ranged from 6 to 11 μg/ml and from 51 to 82 μg/ml, respectively. The enzymatic inhibition produced by these plant extracts is described here for the first time. The results have shown that the phenolic extracts are more potent than the saponin extracts with Ki values ranged from 0.011 mg/ml to 0.027 mg/ml for phenolic extracts, and ranged from 0.071 mg/ml to 0.69 mg/ml for saponin extracts. The nature, mechanism and possible physiological relevance of lipase inhibition by extract components are discussed.
Export Options
About this article
Cite this article as:
Benarous K., Djeridane A., Kameli A. and Yousfi M., Inhibition of Candida rugosa Lipase by Secondary Metabolites Extracts of Three Algerian Plants and their Antioxydant Activities, Current Enzyme Inhibition 2013; 9 (1) . https://dx.doi.org/10.2174/1573408011309010010
DOI https://dx.doi.org/10.2174/1573408011309010010 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
High-Density Lipoprotein: Key Molecule in Cholesterol Efflux and the Prevention of Atherosclerosis
Current Pharmaceutical Design Anticancer Drug Discovery Targeting DNA Hypermethylation
Current Medicinal Chemistry Beta Blockers and Chronic Obstructive Pulmonary Disease (COPD): Sum of Evidence
Current Hypertension Reviews Mechanisms of the Beneficial Actions of Ischemic Preconditioning on Subcellular Remodeling in Ischemic-Reperfused Heart
Current Cardiology Reviews Nutrigenetics, Metabolic Syndrome Risk and Personalized Nutrition
Current Vascular Pharmacology Pathophysiology, Diagnosis and Clinical Management of Hepatorenal Syndrome: From Classic to New Drugs
Current Vascular Pharmacology Updated Electrocardiographic Classification of Acute Coronary Syndromes
Current Cardiology Reviews Peripartum Cardiomyopathy: Current State of Knowledge, New Developments and Future Directions
Current Cardiology Reviews NMR of Membrane-Associated Peptides and Proteins
Current Protein & Peptide Science Plasma Glucose Concentrations and Cardiac Hypertrophy in Essential Hypertension
Current Hypertension Reviews β2-AR-HIF-1α: A Novel Regulatory Axis for Stress-Induced Pancreatic Tumor Growth and Angiogenesis
Current Molecular Medicine Prognostic Value of White Blood Cell Counts and C-reactive Protein in Acute Ischemic Stroke Patients After Intravenous Thrombolysis
Current Neurovascular Research Physical Activity and Insulin Resistance
Current Nutrition & Food Science Effectiveness of Psychoeducational Interventions for Improving Symptoms, Health-Related Quality of Life, and Psychological well Being in Patients with Stable Angina
Current Cardiology Reviews Atrial Fibrillation During or After TAVI: Incidence, Implications and Therapeutical Considerations
Current Pharmaceutical Design The LDL-Receptor and its Molecular Properties: From Theory to Novel Biochemical and Pharmacological Approaches in Reducing LDL-cholesterol
Current Medicinal Chemistry Editorial from Editor-in-Chief (Adherence to CPAP: Understanding the Key to a Successful Treatment)
Current Respiratory Medicine Reviews Novel Ligands: Fine Tuning the Transcriptional Activity of the Glucocorticoid Receptor
Current Pharmaceutical Design The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
Current Cancer Drug Targets Pharmacotherapy in Neonatal and Pediatric Extracorporeal Membrane Oxygenation (ECMO)
Current Drug Metabolism